Publicacións en colaboración con investigadores/as de Hospital Clinic Barcelona (13)

2024

  1. Impact of coronary calcium morphology on intravascular lithotripsy

    EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, Vol. 20, Núm. 10, pp. e656-e668

  2. Ramipril After Transcatheter Aortic Valve Implantation in Patients Without Reduced Ejection Fraction: The RASTAVI Randomized Clinical Trial

    Journal of the American Heart Association, Vol. 13, Núm. 19, pp. e035460

  3. Validation of Quantitative Flow Ratio-Derived Virtual Angioplasty with Post-Angioplasty Fractional Flow Reserve—The QIMERA-I Study

    Journal of Cardiovascular Development and Disease, Vol. 11, Núm. 1

2023

  1. Impact of Age at the Time of the First ST-Elevation Myocardial Infarction on 10-Year Outcomes (from the EXAMINATION-EXTEND Trial)

    American Journal of Cardiology, Vol. 190, pp. 32-40

2022

  1. Angiography-derived physiology guidance vs usual care in an All-comers PCI population treated with the healing-targeted supreme stent and Ticagrelor monotherapy: PIONEER IV trial design

    American Heart Journal, Vol. 246, pp. 32-43

  2. Impact of Diabetes on 10-Year Outcomes Following ST-Segment–Elevation Myocardial Infarction: Insights From the EXAMINATION-EXTEND Trial

    Journal of the American Heart Association, Vol. 11, Núm. 23

  3. One-year cardiovascular outcomes after coronavirus disease 2019: The cardiovascular COVID-19 registry

    PLoS ONE, Vol. 17, Núm. 12 December

  4. Sex Differences in 10-Year Outcomes Following STEMI: A Subanalysis From the EXAMINATION-EXTEND Trial

    JACC: Cardiovascular Interventions, Vol. 15, Núm. 19, pp. 1965-1973

2021

  1. ST-Segment Elevation Myocardial Infarction Following Transcatheter Aortic Valve Replacement

    Journal of the American College of Cardiology, Vol. 77, Núm. 17, pp. 2187-2199

2020

  1. Ramipril in High-Risk Patients With COVID-19

    Journal of the American College of Cardiology, Vol. 76, Núm. 3, pp. 268-276

  2. Transcatheter Aortic Valve Replacement for Residual Lesion of the Aortic Valve Following “Healed” Infective Endocarditis

    JACC: Cardiovascular Interventions, Vol. 13, Núm. 17, pp. 1983-1996

2019

  1. Renin-Angiotensin System Inhibition Following Transcatheter Aortic Valve Replacement

    Journal of the American College of Cardiology, Vol. 74, Núm. 5, pp. 631-641

2018

  1. Impact of renin-angiotensin system inhibitors on clinical outcomes and ventricular remodelling after transcatheter aortic valve implantation: Rationale and design of the RASTAVI randomised multicentre study

    BMJ Open, Vol. 8, Núm. 2